Drug-induced conformational changes in multidrug efflux transporter AcrB from Haemophilus influenzae

Vishakha Dastidar1, Weimin Mao, Olga Lomovskaya

  • 1Department of Chemistry and Biochemistry, 620 Parrington Oval, Norman, OK 73019, USA.

Insights

Multidrug efflux pumps in gram-negative bacteria, like AcrB(HI) from Haemophilus influenzae, confer resistance. Substrate binding induces conformational changes in these transporters, impacting their function.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Gram-negative bacteria utilize Resistance-Nodulation-Cell Division (RND) superfamily transporters for intrinsic multidrug resistance.
  • Haemophilus influenzae produces the AcrB(HI) multidrug efflux transporter, which functions with AcrA(HI) and TolC(HI).

Purpose of the Study:

  • To investigate the in vivo dynamics and substrate-induced conformational changes of the AcrAB(HI) multidrug efflux transporter.
  • To determine if AcrAB(HI) expressed in Escherichia coli requires E. coli's TolC (TolC(EC)) for activity.

Main Methods:

  • Constructed single cysteine mutations in AcrB(HI) at substrate recognition sites.
  • Assessed in vivo accessibility of these cysteines to fluorescein-5-maleimide (FM) in the presence/absence of substrates, AcrA(HI), and TolC(EC).

Main Results:

  • AcrAB(HI) expressed in E. coli conferred multidrug resistance, dependent on TolC(EC).
  • The reactivity of specific cysteines with FM was altered by certain substrates, indicating substrate-specific conformational changes in AcrB(HI).

Conclusions:

  • Substrates induce conformational changes within the AcrB(HI) multidrug efflux transporter.
  • Understanding these dynamics is crucial for developing strategies to combat bacterial multidrug resistance.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types: